Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| NATR | NATURES SUNSHINE PRODUCTS INC | 2025-12-01 22:36:49 | 20.84 | -0.22 | -1.04 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NATR | 0000275053 | NATURES SUNSHINE PRODUCTS INC | US6390271012 | — | 870327982 | Nasdaq | 2834 | Pharmaceutical Preparations | 1231 | UT | 2901 WEST BLUEGRASS BLVD. | LEHI | UT | 84043 | UNITED STATES | US | (801) 341-7900 | 2901 WEST BLUEGRASS BLVD., LEHI, UT, 84043 | 2901 WEST BLUEGRASS BLVD., LEHI, UT, 84043 | — | nutritional supplements | 1972 | Terrence Moorehead | 901 | https://naturessunshine.com/ | 183,438,927 | 17,560,000 | 17,495,563 | Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah. | 2025-11-27 18:09:00 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 183,438,927 | 4,617,607 | 2.5822 | 18,483,501 | -335,560 | -1.7831 |
| 2023 | 178,821,320 | 38,297,687 | 27.2536 | 18,819,061 | -237,250 | -1.245 |
| 2022 | 140,523,633 | -61,422,593 | -30.4153 | 19,056,311 | -392,749 | -2.0194 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Dan Norman | President, Executive Vice President | 2024 | 425,000 | 0 | 425,000 | — | 14,805 | 1,095,212 |
| Terrence Moorehead | Chief Executive Officer, President | 2024 | 832,000 | 0 | 1,456,000 | — | 43,492 | 2,856,526 |
| Shane Jones | Chief Financial Officer, Executive Vice President | 2024 | 460,000 | 0 | 552,000 | — | 14,994 | 1,220,516 |
| Shane Jones | Chief Financial Officer, Executive Vice President | 2023 | 430,000 | 150,000 | 515,993 | — | 14,536 | 1,523,071 |
| Terrence Moorehead | Chief Executive Officer, President | 2023 | 800,000 | 0 | 1,400,002 | — | 42,677 | 3,521,879 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 819 |
| 2023 | 814 |
| 2022 | 800 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 454,364,000 | 445,320,000 | 421,910,000 |
| Cost Of Revenue | 129,676,000 | 124,193,000 | 122,150,000 |
| Gross Profit | 324,688,000 | 321,127,000 | 299,760,000 |
| Research And Development Expenses | 1,700,000 | 1,600,000 | 1,500,000 |
| General And Administrative Expenses | 164,004,000 | 167,058,000 | 153,125,000 |
| Operating Expenses | — | — | — |
| Operating Income | 20,095,000 | 18,749,000 | 16,258,000 |
| Net Income | 7,696,000 | 15,076,000 | 550,000 |
| Earnings Per Share Basic | 0.41 | 0.79 | -0.02 |
| Earnings Per Share Diluted | 0.4 | 0.77 | -0.02 |
| Weighted Average Shares Outstanding Basic | 18,616,000 | 19,066,000 | 19,326,000 |
| Weighted Average Shares Outstanding Diluted | 19,089,000 | 19,466,000 | 19,326,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 84,700,000 | 82,373,000 | 60,032,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 9,477,000 | 8,827,000 | 14,106,000 |
| Inventories | 59,443,000 | 66,895,000 | 67,949,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 160,579,000 | 165,817,000 | 149,507,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 39,585,000 | 45,000,000 | 46,162,000 |
| Other Assets Non Current | 9,333,000 | 9,784,000 | 10,403,000 |
| Total Assets Non Current | 80,276,000 | 83,956,000 | 80,271,000 |
| Total Assets | 240,855,000 | 249,773,000 | 229,778,000 |
| Accounts Payable | 8,912,000 | 7,910,000 | 6,349,000 |
| Deferred Revenue | 2,774,000 | 1,794,000 | 2,255,000 |
| Short Term Debt | — | 0 | 1,174,000 |
| Other Liabilities Current | 25,399,000 | 33,162,000 | 25,591,000 |
| Total Liabilities Current | 65,692,000 | 76,753,000 | 65,582,000 |
| Long Term Debt | — | — | 1,174,000 |
| Other Liabilities Non Current | 1,345,000 | 644,000 | 1,054,000 |
| Total Liabilities Non Current | 14,172,000 | 13,480,000 | 17,149,000 |
| Total Liabilities | 79,864,000 | 90,233,000 | 82,731,000 |
| Common Stock | 114,577,000 | 119,694,000 | 121,583,000 |
| Retained Earnings | 57,407,000 | 49,711,000 | 34,635,000 |
| Accumulated Other Comprehensive Income | -16,671,000 | -15,347,000 | -13,313,000 |
| Total Shareholders Equity | 160,991,000 | 159,540,000 | 147,047,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 14,219,000 | 11,816,000 | 11,025,000 |
| Share Based Compensation Expense | 4,788,000 | 4,893,000 | 2,901,000 |
| Other Non Cash Income Expense | -1,570,000 | 0 | -1,069,000 |
| Change In Accounts Receivable | 1,121,000 | -4,921,000 | 5,942,000 |
| Change In Inventories | -5,562,000 | -995,000 | 8,841,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | 560,000 | -679,000 | -159,000 |
| Change In Accounts Payable | 1,085,000 | 1,422,000 | -2,803,000 |
| Change In Other Liabilities | -5,512,000 | 6,991,000 | -5,608,000 |
| Cash From Operating Activities | 25,298,000 | 41,226,000 | 710,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 10,971,000 | 10,478,000 | 7,628,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -10,971,000 | -10,478,000 | -7,628,000 |
| Tax Withholding For Share Based Compensation | 1,046,000 | 385,000 | 1,129,000 |
| Payments Of Dividends | — | — | 0 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 8,859,000 | 6,397,000 | 13,571,000 |
| Issuance Of Long Term Debt | — | — | 45,005,000 |
| Repayment Of Long Term Debt | 40,991,000 | 16,294,000 | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -9,905,000 | -7,956,000 | -16,246,000 |
| Change In Cash | 2,327,000 | 22,341,000 | -26,152,000 |
| Cash At End Of Period | 84,700,000 | 82,373,000 | 60,032,000 |
| Income Taxes Paid | 14,788,000 | 9,264,000 | 5,609,000 |
| Interest Paid | 119,000 | 539,000 | 264,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 0.41 | 0.79 | -0.02 |
| Price To Earnings Ratio | 35.7561 | 21.8861 | -416 |
| Earnings Growth Rate | -48.1013 | -4,050 | -101.3793 |
| Price Earnings To Growth Ratio | -0.7434 | -0.0054 | 4.1034 |
| Book Value Per Share | 8.648 | 8.3678 | 7.6088 |
| Price To Book Ratio | 1.6952 | 2.0663 | 1.0935 |
| Ebitda | 36,849,000 | 36,225,000 | 17,433,000 |
| Enterprise Value | — | — | 103,108,320 |
| Dividend Yield | — | — | 0 |
| Dividend Payout Ratio | — | — | 0 |
| Debt To Equity Ratio | — | — | 0.016 |
| Capital Expenditures | 8,804,000 | 10,654,000 | 6,330,000 |
| Free Cash Flow | 16,494,000 | 30,572,000 | -5,620,000 |
| Return On Equity | 0.0478 | 0.0945 | 0.0037 |
| One Year Beta | 1.1397 | 1.1917 | 0.5203 |
| Three Year Beta | 0.7579 | 0.7492 | 0.9483 |
| Five Year Beta | 0.9795 | 0.9901 | 0.948 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Lanoy Jonathan David | SVP, Chief Accounting Officer | 2025-11-18 | 5,000 | D | 46,233 |
| Norman Daniel C | EVP & President, Asia | 2025-11-17 | 3,571 | D | 63,065 |
| Brower Nathan G | EVP, General Counsel | 2025-11-14 | 3,800 | D | 46,735 |
| Norman Daniel C | EVP & President, Asia | 2025-11-12 | 8,884 | D | 66,636 |
| Romanzi Kenneth G. | Director, Chief Executive Officer | 2025-11-04 | 102,881 | A | 102,881 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 2025-09-30 | 3,450,095 | 222,300 | 15.52 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2025-09-30 | 1,703,599 | 109,768 | 15.52 |
| NewEdge Advisors, LLC | 2025-09-30 | 242,205 | 15,606 | 15.52 |
| Perritt Capital Management Inc | 2025-09-30 | 388,000 | 25,000 | 15.52 |
| Arax Advisory Partners | 2025-09-30 | 24,475 | 1,577 | 15.52 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| RYDEX SERIES FUNDS | 2025-09-30 | Class C | RYCMX | 21 | 325.92 | 0.0049 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class A | RYAKX | 21 | 325.92 | 0.0049 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYMKX | 21 | 325.92 | 0.0049 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class H | RYRHX | 34 | 527.68 | 0.0043 |
| RYDEX SERIES FUNDS | 2025-09-30 | Class C | RYROX | 34 | 527.68 | 0.0043 |